UK Markets closed

Senseonics Holdings, Inc. (SENS)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.1600+0.0300 (+2.65%)
At close: 04:00PM EDT
1.1500 +0.01 (+0.88%)
After hours: 04:12PM EDT

Senseonics Holdings, Inc.

20451 Seneca Meadows Parkway
Germantown, MD 20876-7005
United States
301 515 7260
https://www.senseonics.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees89

Key executives

NameTitlePayExercisedYear born
Dr. Timothy T. GoodnowPres, CEO & Director1.07MN/A1962
Dr. Mukul JainChief Operating Officer640.66kN/A1973
Dr. Francine Ratner Kaufman M.D.Chief Medical Officer & Director658.44kN/A1951
Mr. Nick B. Tressler M.B.A.CFO, Sec. & TreasurerN/AN/A1973
Mr. Kenneth L. HortonGen. Counsel & Corp. Devel. AdvisorN/AN/A1967
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Corporate governance

Senseonics Holdings, Inc.’s ISS governance QualityScore as of 1 May 2022 is 9. The pillar scores are Audit: 6; Board: 8; Shareholder rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.